Fatemeh Rezaei-Tazangi (Hossein Motedayyen)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Venues

Cell biology international

Zygote (Cambridge, England)

International journal of fertility & sterility

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei-Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough
Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell biology international (2024)
Reza Arefnezhad, Hossein Roghani-Shahraki, Fatemeh Rezaei-Tazangi
Function of MicroRNAs in Normal and Abnormal Ovarian Activities: A Review Focus on MicroRNA-21. International journal of fertility & sterility 18 (2) (2024)
Reza Arefnezhad, Hossein Roghani-Shahraki, Fatemeh Rezaei-Tazangi
Function of MicroRNAs in Normal and Abnormal Ovarian Activities: A Review Focus on MicroRNA-21. International journal of fertility & sterility 18 (2) (2024)
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei-Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough
Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell biology international 48 (5) (2024)
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei-Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough
Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell biology international 48 (5) (2024)
Reza Arefnezhad, Hossein Roghani-Shahraki, Fatemeh Rezaei-Tazangi
Function of MicroRNAs in Normal and Abnormal Ovarian Activities: A Review Focus on MicroRNA-21. International journal of fertility & sterility 18 (2) (2024)
Reza Arefnezhad, Hossein Roghani-Shahraki, Fatemeh Rezaei-Tazangi
Function of MicroRNAs in Normal and Abnormal Ovarian Activities: A Review Focus on MicroRNA-21. International journal of fertility & sterility 18 (2) (2024)
Fereshteh Aliakbari, Neda Taghizabet, Fatemeh Rezaei-Tazangi, Hamid Kalantari, Ahmad Vosough Dizaj, Maryam Mohammadi, Hesamoddin Sajadi, Mohammad Ali Sadighi Gilani
Evaluation of Predicting Factors Affecting Sperm Retrieval in Patients with Klinefelter Syndrome: A Prospective Study. International journal of fertility & sterility 17 (4) (2023)
Fatemeh Rezaei-Tazangi, Leila Kooshesh, Ali Tayyebiazar, Neda Taghizabet, Anahita Tavakoli, Ashraf Hassanpour, Fereshteh Aliakbari, Ebrahim Kharazinejad, Ali-Mohammad Sharifi
Effects of kisspeptin on the maturation of human ovarian primordial follicles in vitro . Zygote (Cambridge, England) 32 (1) (2023)
Fatemeh Rezaei-Tazangi, Leila Kooshesh, Ali Tayyebiazar, Neda Taghizabet, Anahita Tavakoli, Ashraf Hassanpour, Fereshteh Aliakbari, Ebrahim Kharazinejad, Ali-Mohammad Sharifi
Effects of kisspeptin on the maturation of human ovarian primordial follicles in vitro . Zygote (Cambridge, England) (2023)
Reza ArefNezhad, Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Pouya Goleij, Nabi Zare, Hossein Motedayyen, Elaheh Aghazadeh
Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell biology international 47 (4) (2023)
Reza ArefNezhad, Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Pouya Goleij, Nabi Zare, Hossein Motedayyen, Elaheh Aghazadeh
Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell biology international 47 (4) (2023)
Reza ArefNezhad, Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Pouya Goleij, Nabi Zare, Hossein Motedayyen, Elaheh Aghazadeh
Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell biology international (2023)
Fatemeh Rezaei-Tazangi, Leila Kooshesh, Ali Tayyebiazar, Neda Taghizabet, Anahita Tavakoli, Ashraf Hassanpour, Fereshteh Aliakbari, Ebrahim Kharazinejad, Ali-Mohammad Sharifi
Effects of kisspeptin on the maturation of human ovarian primordial follicles in vitro . Zygote (Cambridge, England) 32 (1) (2023)
Tayebe Pouryousefi-Koodehi, Shika Shayegan, Soheyla Hashemi, Reza Arefnezhad, Hossein Roghani-Shahraki, Hossein Motedayyen, Neda Taghizabet, Fatemeh Rezaei-Tazangi
Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review. Zygote (Cambridge, England) 30 (5) (2022)
Neda Taghizabet, Fatemeh Rezaei-Tazangi, Mahboubeh Mousavi, Farzaneh Dehghani, Nehleh Zareifard, Soha Shabani, Soghra Bahmanpour, Fereshteh Aliakbari, Zahra Sadeghzadeh, Hengameh Dortaj, Arezoo Chakerzehi, Gholamreza Mohseni
Endometrial cell-derived conditioned medium in combination with platelet-rich plasma promotes the development of mouse ovarian follicles. Zygote (Cambridge, England) (2022)
Anahita Tavakoli, Mohammad Saeed Kahrizi, Kimia Safa, Reza ArefNezhad, Fatemeh Rezaei-Tazangi
Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview. Molecular biology reports 49 (9) (2022)
Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Mahdi Khorsand Ghaffari, Firoozeh Abolhasani Zadeh, Aynaz Boostan, Reza ArefNezhad, Hossein Motedayyen
The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)

Fatemeh Rezaei-Tazangi.css-eqlu8i{font-size:small;padding-left:4px;} (Hossein Motedayyen)

Publication Activity (10 Years)

Top Topics

Top Venues

Fatemeh Rezaei-Tazangi (Hossein Motedayyen)